Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Pugliese

Showing results (21-30 of 175) with videos related to

Pageof 18
Sort By:
Acta Diabetologica|March 13, 2017
The impact of type 1 diabetes and diabetic polyneuropathy on muscle strength and fatigabilityGiorgio Orlando, Stefano Balducci, Ilenia Bazzucchi, et al.
Cells|May 10, 2024
Impaired Remodeling of White Adipose Tissue in Obesity and Aging: From Defective Adipogenesis to Adipose Organ DysfunctionCarla Iacobini, Martina Vitale, Jonida Haxhi, et al.
Metabolism: Clinical and Experimental|November 21, 2018
Metabolically healthy versus metabolically unhealthy obesityCarla Iacobini, Giuseppe Pugliese, Claudia Blasetti Fantauzzi, et al.
Diabetologia|December 5, 2014
Protection from diabetes-induced atherosclerosis and renal disease by D-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in Apoe-null miceStefano Menini, Carla Iacobini, Carlo Ricci, et al.
Clinical Chemistry and Laboratory Medicine|June 19, 2014
Galectin-3 in diabetic patientsGiuseppe Pugliese, Carla Iacobini, Carlo Ricci, et al.
Clinical and Translational Medicine|February 26, 2021
Restoration of renal TIMP3 levels via genetics and pharmacological approach prevents experimental diabetic nephropathyViviana Casagrande, Giulia Iuliani, Stefano Menini, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|April 22, 2021
The Quality of Life of Thalassemic Patients: The Role of Endocrine Defect CompensationLorenza Mattia, Irene Samperi, Salvatore Monti, et al.
Antioxidants (Basel, Switzerland)|November 11, 2022
Mutual Regulation between Redox and Hypoxia-Inducible Factors in Cardiovascular and Renal Complications of DiabetesCarla Iacobini, Martina Vitale, Jonida Haxhi, et al.
Tumori|August 23, 2021
Cemiplimab- and nivolumab-induced myasthenia gravis: two clinical casesFabio Canino, Giuseppe Pugliese, Cinzia Baldessari, et al.
Tumori|December 5, 2023
Demyelinating polyradiculoneuropathy during dabrafenib and trametinib treatment for metastatic melanoma: A case reportMarta Venturelli, Stefano Greco, Cinzia Baldessari, et al.
Pageof 18

Showing results (21-30 of 175) with videos related to

Sort By:
Pageof 18
Acta Diabetologica|March 13, 2017
The impact of type 1 diabetes and diabetic polyneuropathy on muscle strength and fatigabilityGiorgio Orlando, Stefano Balducci, Ilenia Bazzucchi, et al.
Cells|May 10, 2024
Impaired Remodeling of White Adipose Tissue in Obesity and Aging: From Defective Adipogenesis to Adipose Organ DysfunctionCarla Iacobini, Martina Vitale, Jonida Haxhi, et al.
Metabolism: Clinical and Experimental|November 21, 2018
Metabolically healthy versus metabolically unhealthy obesityCarla Iacobini, Giuseppe Pugliese, Claudia Blasetti Fantauzzi, et al.
Diabetologia|December 5, 2014
Protection from diabetes-induced atherosclerosis and renal disease by D-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in Apoe-null miceStefano Menini, Carla Iacobini, Carlo Ricci, et al.
Clinical Chemistry and Laboratory Medicine|June 19, 2014
Galectin-3 in diabetic patientsGiuseppe Pugliese, Carla Iacobini, Carlo Ricci, et al.
Clinical and Translational Medicine|February 26, 2021
Restoration of renal TIMP3 levels via genetics and pharmacological approach prevents experimental diabetic nephropathyViviana Casagrande, Giulia Iuliani, Stefano Menini, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|April 22, 2021
The Quality of Life of Thalassemic Patients: The Role of Endocrine Defect CompensationLorenza Mattia, Irene Samperi, Salvatore Monti, et al.
Antioxidants (Basel, Switzerland)|November 11, 2022
Mutual Regulation between Redox and Hypoxia-Inducible Factors in Cardiovascular and Renal Complications of DiabetesCarla Iacobini, Martina Vitale, Jonida Haxhi, et al.
Tumori|August 23, 2021
Cemiplimab- and nivolumab-induced myasthenia gravis: two clinical casesFabio Canino, Giuseppe Pugliese, Cinzia Baldessari, et al.
Tumori|December 5, 2023
Demyelinating polyradiculoneuropathy during dabrafenib and trametinib treatment for metastatic melanoma: A case reportMarta Venturelli, Stefano Greco, Cinzia Baldessari, et al.
Pageof 18